EDGAR Filing Documents for 0001524679-12-000001

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001524679-12-000001

Filing Date

2012-08-14

Accepted

2012-08-14 16:19:49

Documents

Effectiveness Date

2012-08-14

Items

Item 04: Rule 504(b)(1) (not (i), (ii) or (iii))
Item 04.1: Rule 504(b)(1)(i)
Item 04.2: Rule 504(b)(1)(ii)
Item 04.3: Rule 504(b)(1)(iii)
Item 05: Rule 505
Item 06: Rule 506
Item 46: Securities Act Section 4(6)

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	5095
	Complete submission text file	0001524679-12-000001.txt		6374

Mailing Address 244 5TH AVENUE SUITE 1727 NEW YORK NY 10001

Business Address 244 5TH AVENUE SUITE 1727 NEW YORK NY 10001 5407600535

Immune Response BioPharma, Inc. (Filer) CIK: 0001524679 (see all company filings)